Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (231-240 of 324) with videos related to

Pageof 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2014
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trialAlan Winston, Janaki Amin, Amanda Clarke, et al.
Journal of the International AIDS Society|October 22, 2011
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan AfricaRichard G Wamai, Brian J Morris, Stefan A Bailis, et al.
Atherosclerosis|June 12, 2009
Lipoprotein particle subclasses, cardiovascular disease and HIV infectionDaniel A Duprez, Lewis H Kuller, Russell Tracy, et al.
The Lancet. Infectious Diseases|March 14, 2013
The search for an HIV cure: tackling latent infectionStephen J Kent, Jeanette C Reece, Janka Petravic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Characterization of CD4(+) CTLs ex vivoVictor Appay, John J Zaunders, Laura Papagno, et al.
AIDS Research and Human Retroviruses|December 5, 2018
HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen ExposureWilliam J Hey-Nguyen, Michelle Bailey, Yin Xu, et al.
Journal of Virology|September 29, 2006
CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cellsJohn J Zaunders, Wayne B Dyer, Mee Ling Munier, et al.
AIDS (London, England)|August 23, 2011
Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapyJason V Baker, Jacqueline Neuhaus, Daniel Duprez, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2005
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patientsReshma Saskia Autar, Marta Boffito, Elly Hassink, et al.
AIDS Research and Human Retroviruses|June 28, 2016
Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE StudyEdward P Lam, Cecilia L Moore, Eduardo Gotuzzo, et al.
Pageof 33

Showing results (231-240 of 324) with videos related to

Sort By:
Pageof 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2014
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trialAlan Winston, Janaki Amin, Amanda Clarke, et al.
Journal of the International AIDS Society|October 22, 2011
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan AfricaRichard G Wamai, Brian J Morris, Stefan A Bailis, et al.
Atherosclerosis|June 12, 2009
Lipoprotein particle subclasses, cardiovascular disease and HIV infectionDaniel A Duprez, Lewis H Kuller, Russell Tracy, et al.
The Lancet. Infectious Diseases|March 14, 2013
The search for an HIV cure: tackling latent infectionStephen J Kent, Jeanette C Reece, Janka Petravic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Characterization of CD4(+) CTLs ex vivoVictor Appay, John J Zaunders, Laura Papagno, et al.
AIDS Research and Human Retroviruses|December 5, 2018
HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen ExposureWilliam J Hey-Nguyen, Michelle Bailey, Yin Xu, et al.
Journal of Virology|September 29, 2006
CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cellsJohn J Zaunders, Wayne B Dyer, Mee Ling Munier, et al.
AIDS (London, England)|August 23, 2011
Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapyJason V Baker, Jacqueline Neuhaus, Daniel Duprez, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2005
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patientsReshma Saskia Autar, Marta Boffito, Elly Hassink, et al.
AIDS Research and Human Retroviruses|June 28, 2016
Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE StudyEdward P Lam, Cecilia L Moore, Eduardo Gotuzzo, et al.
Pageof 33